The Shrinking Lungs Syndrome (SLS) is a rare pulmonary disorder associated with diaphragmatic dysfunction in patients with systemic lupus erythematosus (SLE).
Patient selection: SLE
Clinical features:
(1) dyspnea
(2) reduced exercise capacity
(3) restrictive pattern on pulmonary function testing (PFT)
Imaging studies:
(1) small lung volumes for age and gender
(2) elevated diaphragm (unilateral or bilateral)
(3) basilar atelectasis
Additional studies demonstrate:
(1) diaphragmantic dysfunction on electromyogaphy
(2) phrenic nerve palsy on phrenic nerve stimulation
(3) esophageal and gastric pressure measurements
Differential diagnosis:
(1) myopathy (especially after high dose corticosteroid therapy)
(2) other syndromes of pulmonary and/or pleural involvement in SLE
Therapy may include use of corticosteroids, inhaled beta-agonists, immunosuppression and/or theophylline.
Purpose: To evaluate a patient with systemic lupus erythematosus (SLE) for evidence of the shrinking lungs syndrome (SLS).
Specialty: Immunology/Rheumatology
Objective: imaging studies, laboratory tests, criteria for diagnosis, pharmacogenetics, disease progression, complication detection
ICD-10: J98.4, M32,